• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Glycosyl compounds

Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside (CAS No. 52554-28-6): An Overview of Its Synthesis, Applications, and Recent Research

Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside (CAS No. 52554-28-6) is a significant compound in the field of organic and medicinal chemistry. This compound is a methyl ester derivative of D-ribofuranose, where the hydroxyl groups at positions 2, 3, and 5 are acetylated. The acetylation process provides stability and protection to the sugar moiety, making it a valuable intermediate in the synthesis of nucleosides and other biologically active compounds.

The synthesis of Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside involves several well-documented steps. Initially, D-ribose is converted to its methyl ester derivative through a reaction with methanol in the presence of an acid catalyst. Subsequently, the hydroxyl groups are acetylated using acetic anhydride in the presence of a base such as pyridine. This process yields the fully protected sugar derivative with high purity and yield.

One of the primary applications of Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside is in the synthesis of nucleosides and nucleotides. Nucleosides are fundamental building blocks of DNA and RNA and play crucial roles in various biological processes. The acetylated sugar moiety provides a stable platform for further functionalization, allowing chemists to introduce various nucleobases and other functional groups. This versatility makes Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside an essential intermediate in the development of novel therapeutic agents.

Recent research has highlighted the potential of Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside in the development of antiviral drugs. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent antiviral activity against several RNA viruses. The acetylated sugar moiety was found to enhance the stability and bioavailability of the resulting nucleosides, thereby improving their therapeutic efficacy.

In addition to its role in antiviral drug development, Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside has also been explored for its potential in cancer therapy. A study conducted by researchers at the University of California found that certain derivatives of this compound can inhibit key enzymes involved in cancer cell proliferation. The acetylated sugar moiety was shown to enhance the selectivity and potency of these derivatives against cancer cells while minimizing toxicity to normal cells.

The structural properties of Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside have also been studied extensively using various spectroscopic techniques such as NMR and X-ray crystallography. These studies have provided valuable insights into the conformational preferences and dynamic behavior of the molecule in solution and solid-state environments. Understanding these properties is crucial for optimizing its use in synthetic routes and biological applications.

In conclusion, Methyl 2,3,5-tri-O-acetyl-D-ribofuranoside (CAS No. 52554-28-6) is a versatile and important compound with wide-ranging applications in organic synthesis and medicinal chemistry. Its ability to serve as a stable intermediate for the synthesis of nucleosides and other biologically active compounds makes it an indispensable tool for researchers working on drug discovery and development. Ongoing research continues to uncover new potential uses for this compound, further solidifying its importance in the field.

• 604-68-2([(2R,3R,4S,5R,6R)-3,4,5,6-tetrakis(acetyloxy)oxan-2-yl]methyl acetate)
• 22352-19-8(Octaacetyl-β-maltose)
• 4163-60-4([(2R,3S,4S,5R,6S)-3,4,5,6-tetrakis(acetyloxy)oxan-2-yl]methyl acetate)
• 126-14-7(Sucrose octaacetate)
• 5346-90-7(α-D-Cellobiose octaacetate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)